Day: July 7, 2021

<div>atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit</div>

atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

BERLIN, Germany, July 07, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, today announced that it will present and participate in one-on-one investor meetings at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13, 2021. Presentation details can be found below. Date: Tuesday, July 13, 2021 Time: 10:50 AM ET Webcast link: https://wsw.com/webcast/cowen86/atai/1936406 A replay of the presentation will be available in the “Events” section of the atai Life Sciences website at ir.atai.life. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded...

Continue reading

South Grass Valley Drilling Update

South Grass Valley Drilling Update

South Grass Valley Project (SGVC012 1,346 – 1,349 metres) South Grass Valley Project (SGVC012 1,346 – 1,349 metres) South Grass Valley Project Northern drill holes (July 7, 2021) South Grass Valley Project Northern drill holes (July 7, 2021) South Grass Valley Project Southern drill holes (July 7, 2021) South Grass Valley Project Southern drill holes (July 7, 2021) RENO, Nev., July 07, 2021 (GLOBE NEWSWIRE) — Nevada Exploration Inc. (“NGE” or the “Company”) (TSX-V:NGE; OTCQB:NVDEF) is pleased to provide an update from its 2021 core drilling program at its South Grass Valley Carlin-type gold project. Summary: During May, the Company completed the first hole of the program, SGVC012, to a final depth of 1,405 metres, successfully sampling the lower-plate Clm unit that hosts NGE’s primary...

Continue reading

DoubleDown Interactive Files Amendment To Registration Statement With B. Riley Securities As Lead Left Bookrunner

DoubleDown Interactive Files Amendment To Registration Statement With B. Riley Securities As Lead Left Bookrunner

SEATTLE and SEOUL, July 07, 2021 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd., organized under the laws of the Republic of Korea (the “Company”), a subsidiary of Korea-based DoubleU Games Co., Ltd., announced today that it has engaged B. Riley Securities, Inc. as the lead underwriter of its previously announced proposed U.S. initial public offering of its common shares in the form of American Depositary Shares (the “ADSs”). The ADSs have been approved for listing on the NASDAQ Stock Market (“NASDAQ”) under the symbol “DDI.” Macquarie Capital (USA) Inc. will remain as an active underwriter. A post-effective amendment to the Company’s registration statement on Form F-1 relating to these securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) but has not yet become effective. These securities...

Continue reading

Vincent Lien Resigns From Board

Vincent Lien Resigns From Board

Not for distribution to the U.S. news wire services, or dissemination in the United States. HONG KONG, July 07, 2021 (GLOBE NEWSWIRE) — ‎Primeline Energy Holdings Inc. (“Primeline” or the “Company”) regrets to announce that Vincent J.J. Lien has resigned as a director of Primeline. Primeline is grateful for Mr. Lien’s contribution, and thanks him for his service. Primeline confirms that, other than as disclosed in prior press releases, there have been no ‎material business developments since its press release of August 21, 2020 and the filing on February ‎‎13, 2020 of the Company’s latest interim financial report for the period ended December 31, 2019.‎ ON BEHALF OF PRIMELINE ENERGY HOLDINGS INC. Signed “Andrew Biggs”Chief Executive Officer Contact: Primeline Energy Holding Inc. Andrew Biggs, CEOPH: +44 207.499.8888Fax: +44...

Continue reading

Polypropylene Market to Touch USD 108.57 Billion by 2028; Extensive Adoption of Plastics in the Packaging Industry to Ensure Stable Market Growth, Says Fortune Business Insights™

Polypropylene Market to Touch USD 108.57 Billion by 2028; Extensive Adoption of Plastics in the Packaging Industry to Ensure Stable Market Growth, Says Fortune Business Insights™

Top companies covered in polypropylene market research report are Beaulieu International Group (Belgium), Borealis AG (Austria), Repsol (Spain), Braskem (Brazil), Formosa Plastic Group (Taiwan), Ducor Petrochemicals (Netherlands), China Petroleum & Chemical Corporation (China), China National Petroleum Corporation (China), LyondellBasell Industries N.V. (Netherlands), and more players profiled. Pune, India, July 07, 2021 (GLOBE NEWSWIRE) — The global polypropylene market size is projected to reach USD 108.57 billion by 2028, exhibiting a CAGR of 5.2% during the forecast period. As per the report by Fortune Business Insights™, titled “Polypropylene Market Size, Share & COVID-19 Impact Analysis, By Type (Homopolymer, Copolymer), By End User (Packaging, Automotive, Infrastructure & Construction, Consumer Goods/Lifestyle,...

Continue reading

Agrico Acquisition Corp. Announces Pricing of $125 Million Initial Public Offering

Agrico Acquisition Corp. Announces Pricing of $125 Million Initial Public Offering

Houston, Texas , July 07, 2021 (GLOBE NEWSWIRE) — Agrico Acquisition Corp. (the “Company”), a newly organized blank check company incorporated as a Cayman Islands exempted company and led by Chairman and CEO Brent de Jong, today announced the pricing of its initial public offering of 12,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Nasdaq Capital Market (“NASDAQ”) under the ticker symbol “RICOU” beginning July 8, 2021. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on the NASDAQ...

Continue reading

GWG Holdings Announces Receipt of Notice from Nasdaq Regarding Potential Delisting

GWG Holdings Announces Receipt of Notice from Nasdaq Regarding Potential Delisting

DALLAS, July 07, 2021 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq: GWGH) today announced that it received a Staff Determination letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating that the Company had not established compliance with Rule 5620(a), which requires that GWG hold an annual meeting of shareholders within 12 months of the company’s fiscal year end, and Rule 5250(c)(1), because GWG has not yet filed its Form 10-K for the year ended December 31, 2020 and Form 10-Q for the period ended March 31, 2021. As a result, the Company’s common stock is subject to delisting from The Nasdaq Capital Market. The Company has requested a hearing before a Nasdaq Hearings Panel to review the Staff Determination, which request will stay the delisting of the Company’s common stock for a period of 15 days...

Continue reading

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

Company Selected to Receive the “Pioneer in Technology Award” NEWTOWN, Pa., July 07, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced it will participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics, which will be held from July 8-11th in Los Angeles, California. The Company has been selected to receive the Pioneer in Technology Award during the event, an award presented by the Society to trail blazing companies who have facilitated the development of pioneering technologies through interdisciplinary approaches that have impacted diagnostics, treatment and healthcare delivery in unprecedented ways. Dr. Jonathan Sackier, Helius’ Co-Founder and Medical Advisor, will...

Continue reading

Educational Development Corporation Announces Record First Quarter Fiscal Year 2022 Results

Educational Development Corporation Announces Record First Quarter Fiscal Year 2022 Results

TULSA, Okla., July 07, 2021 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) today reports record first quarter net revenues and increased earnings per share results for the quarter ended May 31, 2021. First Quarter Highlights Compared to the Prior Year First Quarter Net revenues of $40.8 million, an increase of $2.5 million, or 6.5%, compared to $38.3 million. Average active UBAM sales consultants totaled 55,100. Earnings before income taxes were $4.7 million, an increase of $2.1 million, or 80.8%, compared to $2.6 million. Net earnings totaled $3.4 million, compared to $1.9 million, an increase of $1.5 million, or 78.9%. Earnings per share totaled $0.41, compared to $0.23, up 78.3% on a fully diluted basis. “I am truly pleased by our record breaking fiscal...

Continue reading

Evaxion Biotech to Host Conference Call on EVX-01 and EVX-02 Phase 1/2a Data on July 8

Evaxion Biotech to Host Conference Call on EVX-01 and EVX-02 Phase 1/2a Data on July 8

COPENHAGEN, Denmark, July 07, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today that it will hold a conference call to discuss Phase 1/2a data on EVX-01 and EVX-02 on Thursday, July 8, 2021. Lars Wegner, CEO of Evaxion, Glenn Vraniak, CFO, and Niels Iversen Moller, co-founder and CBO, will host the call, at 8:00 a.m. EDT. To dial in for the conference call, please use the following details: Date: July 8, 2021Time: 8:00 AM EDTUS Dial-in: 877-407-0792International Dial-in: + 1-201-689-8263Conference ID: 13720456Webcast: http://public.viavid.com/index.php?id=145224 Slides will accompany the event and a live webcast of the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.